X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3242) 3242
Publication (393) 393
Book / eBook (54) 54
Book Review (45) 45
Newspaper Article (43) 43
Newsletter (41) 41
Book Chapter (33) 33
Magazine Article (7) 7
Conference Proceeding (3) 3
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2304) 2304
index medicus (1849) 1849
humans (1757) 1757
immunology (1470) 1470
antigens (1282) 1282
female (1103) 1103
mice (1086) 1086
antigens, protozoan - immunology (981) 981
parasitic diseases (866) 866
malaria (832) 832
parasitology (819) 819
parasites (805) 805
vaccines (750) 750
proteins (737) 737
infections (671) 671
male (638) 638
infectious diseases (631) 631
medicine, research & experimental (594) 594
protozoan proteins - immunology (536) 536
mice, inbred balb c (522) 522
research article (508) 508
antibodies, protozoan - blood (497) 497
health aspects (477) 477
research (475) 475
immunization (472) 472
antibodies (449) 449
infection (446) 446
vaccination (439) 439
microbiology (427) 427
immune response (416) 416
antigens, protozoan - genetics (415) 415
plasmodium falciparum (413) 413
adult (408) 408
medicine (398) 398
analysis (395) 395
protozoan proteins - genetics (390) 390
immunity (384) 384
plasmodium falciparum - immunology (384) 384
tropical medicine (378) 378
vaccine (357) 357
antigen (339) 339
enzyme-linked immunosorbent assay (339) 339
allergy and immunology (337) 337
lymphocytes (326) 326
t cells (322) 322
multidisciplinary sciences (312) 312
malaria vaccines - immunology (310) 310
dendritic cells (306) 306
immune system (304) 304
cytokines (302) 302
science (290) 290
protozoan vaccines - immunology (285) 285
vector-borne diseases (282) 282
veterinary sciences (279) 279
diagnosis (254) 254
biology (252) 252
article (249) 249
middle aged (247) 247
antibodies, protozoan - immunology (246) 246
molecular sequence data (243) 243
medical research (242) 242
child (240) 240
adolescent (238) 238
expression (237) 237
amino acid sequence (233) 233
lymphocytes t (230) 230
leishmaniasis (229) 229
visceral leishmaniasis (227) 227
tropical diseases (226) 226
studies (225) 225
mice, inbred c57bl (222) 222
immune-responses (215) 215
plasmodium-falciparum (208) 208
malaria, falciparum - immunology (207) 207
gene expression (206) 206
protective immunity (205) 205
erythrocytes (202) 202
immunogenicity (201) 201
cell biology (200) 200
immunoglobulin g - blood (198) 198
plasmodium falciparum - genetics (198) 198
child, preschool (192) 192
dna (192) 192
genetic aspects (192) 192
immunoglobulin g (190) 190
malaria, falciparum - prevention & control (188) 188
immune-response (186) 186
immunoglobulins (186) 186
malaria vaccine (185) 185
disease models, animal (183) 183
polymerase chain reaction (183) 183
physiological aspects (175) 175
cutaneous leishmaniasis (174) 174
immunotherapy (174) 174
antimalarials - therapeutic use (170) 170
recombinant proteins - immunology (169) 169
biology and life sciences (168) 168
identification (167) 167
malaria - immunology (167) 167
arctic medicine. tropical medicine (165) 165
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (38) 38
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Toronto East General Hospital - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Humber River Regional Hospital - Church Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3373) 3373
French (9) 9
Spanish (8) 8
Polish (5) 5
German (4) 4
Japanese (2) 2
Chinese (1) 1
Italian (1) 1
Portuguese (1) 1
Romanian (1) 1
Russian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Nanobiotechnology, ISSN 1477-3155, 09/2017, Volume 15, Issue 1, pp. 62 - 10
Background: The parasitic disease malaria remains a major global public health concern and no truly effective vaccine exists. One approach to the development... 
Protein nanoparticles | Self-assembly | Malaria | P27 | P27A | Vaccine | Blood stage | Tex1 | CIRCUMSPOROZOITE PROTEIN | T-CELL EPITOPES | NANOSCIENCE & NANOTECHNOLOGY | ANTIGENS | HUMAN INHIBITORY ANTIBODIES | HELPER EPITOPES | RESPONSES | INVASION | PEPTIDES | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | PLASMODIUM-FALCIPARUM | MHC CLASS-II | Malaria, Falciparum - prevention & control | Antigens, Protozoan - immunology | Nanoparticles - chemistry | Humans | Plasmodium falciparum - immunology | Protozoan Proteins - therapeutic use | Protozoan Proteins - genetics | Malaria Vaccines - chemistry | Proliferating Cell Nuclear Antigen - genetics | Nanoparticles - therapeutic use | Plasmodium falciparum - genetics | Antigens, Protozoan - therapeutic use | Malaria Vaccines - immunology | Protein Engineering | Protein Domains | Proliferating Cell Nuclear Antigen - immunology | Protozoan Proteins - chemistry | Antigens, Protozoan - genetics | Malaria Vaccines - therapeutic use | Plasmodium falciparum - chemistry | Amino Acid Sequence | Immunization | Antigens, Protozoan - chemistry | Models, Molecular | Proliferating Cell Nuclear Antigen - chemistry | Animals | Malaria, Falciparum - immunology | Mice | Mice, Inbred BALB C | Proliferating Cell Nuclear Antigen - therapeutic use | Protozoan Proteins - immunology | Malaria Vaccines - genetics | Proteins | Prevention | Plasmodium falciparum | Immune response | Parasitic diseases | Analysis | Research | Health aspects | Public health | Coils | Animal models | Candidates | Peptides | Delivery systems | Amino acids | Vaccines | Nanoparticles | Lymphocytes | Low cost | Cross-protection | Immune system | Vector-borne diseases | Antigens | Immunoglobulins | Particulates | Epitopes | Immunogenicity | Scaffolding | Protein expression | Scaffolds
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 2017, Volume 34, Issue 9, pp. 1970 - 1983
PURPOSE: Production and characterization of a chimeric fusion protein (GMZ2'.10C) which combines epitopes of key malaria parasite antigens: glutamate-rich... 
production and stability analysis of biopharmaceuticals | TARGET | Pfs48/45 | LACTOCOCCUS | PROTECTION | STABILITY | ANTIGEN PFS48/45 | disulphide bond mapping | malaria vaccine | CHROMATOGRAPHY | CHEMISTRY, MULTIDISCIPLINARY | MEROZOITE SURFACE PROTEIN-3 | GLUTAMATE-RICH PROTEIN | mass spectrometry of biopharmaceuticals | IMMUNOAFFINITY PURIFICATION | PHARMACOLOGY & PHARMACY | TRANSMISSION-BLOCKING ANTIBODIES | Recombinant Fusion Proteins - immunology | Malaria, Falciparum - prevention & control | Antigens, Protozoan - immunology | Rats, Wistar | Humans | Recombinant Fusion Proteins - therapeutic use | Plasmodium falciparum - immunology | Protozoan Proteins - therapeutic use | Protozoan Proteins - genetics | Malaria Vaccines - chemistry | Plasmodium falciparum - genetics | Antigens, Protozoan - therapeutic use | Cloning, Molecular | Malaria Vaccines - immunology | Protozoan Proteins - chemistry | Antigens, Protozoan - genetics | Malaria Vaccines - therapeutic use | Protein Stability | Plasmodium falciparum - chemistry | Lactococcus lactis - genetics | Amino Acid Sequence | Antigens, Protozoan - chemistry | Recombinant Fusion Proteins - chemistry | Malaria, Falciparum - parasitology | Animals | Malaria, Falciparum - immunology | Antibody Formation | Recombinant Fusion Proteins - genetics | Plasmodium falciparum - growth & development | Protozoan Proteins - immunology | Malaria Vaccines - genetics | Proteins | Plasmodium falciparum | Cysteine | Malaria | Analysis | Malaria vaccine | Vaccines | Glutamate | Mass spectrometry | Antigenic determinants | Protein binding | Lactococcus lactis | Structural stability | Protein purification | Disulfides | Antibodies | Purity | Mapping | Parasites | Western blotting | Rodents | Fusion protein | Enzyme-linked immunosorbent assay | Vector-borne diseases | Antigens | Purification | Mass spectroscopy | Stability analysis | Liquid chromatography | C-Terminus | High-performance liquid chromatography | Peptide mapping | Disease transmission | Connectivity | Structural analysis
Journal Article
The Journal of Immunology, ISSN 0022-1767, 04/2001, Volume 166, Issue 8, pp. 5122 - 5128
DNA- and protein- based vaccines against cutaneous leishmaniasis due to Leishmania major were evaluated using a challenge model that more closely reproduces... 
CUTANEOUS LEISHMANIASIS | GENETIC IMMUNIZATION | IMMUNE-RESPONSE | PROTECTIVE IMMUNITY | CELLULAR-IMMUNITY | INTERFERON-GAMMA | MURINE LEISHMANIASIS | PLASMID DNA | CIRCUMSPOROZOITE PROTEIN | IMMUNOLOGY | CD8(+) T-CELLS | Antigens, Surface - therapeutic use | Leishmania major - immunology | Antigens, Protozoan - immunology | Vaccines, Synthetic - immunology | Leishmaniasis, Cutaneous - immunology | Hypersensitivity, Delayed - immunology | Antigens, Surface - administration & dosage | Leishmaniasis, Cutaneous - transmission | Antigens, Protozoan - therapeutic use | Immunization Schedule | Protozoan Proteins - administration & dosage | Protozoan Vaccines - genetics | Protozoan Vaccines - immunology | Leishmaniasis, Cutaneous - pathology | DNA, Protozoan - therapeutic use | Vaccines, DNA - therapeutic use | Protozoan Vaccines - administration & dosage | Interleukin-12 - administration & dosage | Insect Vectors - parasitology | Interleukin-12 - immunology | Mice | Mice, Inbred BALB C | Protozoan Vaccines - therapeutic use | DNA, Protozoan - immunology | Dose-Response Relationship, Immunologic | Interleukin-12 - genetics | Leishmania major - genetics | Vaccines, DNA - immunology | Variant Surface Glycoproteins, Trypanosoma | Protozoan Proteins - therapeutic use | Protozoan Proteins - genetics | Vaccines, DNA - administration & dosage | Leishmaniasis, Cutaneous - prevention & control | Immunization, Secondary | Leishmania major - growth & development | Antigens, Protozoan - administration & dosage | DNA, Protozoan - administration & dosage | Antigens, Protozoan - genetics | Interleukin-12 - therapeutic use | Psychodidae - parasitology | Injections, Intradermal | Mice, Inbred C57BL | Antigens, Surface - genetics | Vaccines, Synthetic - therapeutic use | Immunity, Innate | Animals | DNA, Protozoan - genetics | Immunologic Memory | Vaccines, Synthetic - administration & dosage | Antigens, Surface - immunology | Protozoan Proteins - immunology
Journal Article
Vaccine, ISSN 0264-410X, 2009, Volume 27, Issue 23, pp. 3090 - 3098
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0159449
Malaria vaccine development has been hampered by the limited availability of antigens identified through conventional discovery approaches, and improvements... 
IMMUNIZATION | PARASITES | PROTECTIVE IMMUNITY | CD8+ T-CELLS | STERILE IMMUNITY | EFFICACY | DNA | MULTIDISCIPLINARY SCIENCES | SPOROZOITES | NAIVE ADULTS | PLASMODIUM-BERGHEI MALARIA | Malaria, Falciparum - drug therapy | Vaccines, DNA - genetics | Antigens, Protozoan - immunology | Antibodies, Protozoan - immunology | Humans | Mice, Inbred C57BL | Vaccines, DNA - immunology | Plasmodium falciparum - immunology | Plasmodium yoelii - immunology | Vaccines, DNA - therapeutic use | Malaria, Falciparum - parasitology | Animals | Antibodies, Protozoan - therapeutic use | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Plasmodium falciparum - pathogenicity | Female | Malaria Vaccines - therapeutic use | Mice | Protozoan Proteins - immunology | Malaria Vaccines - genetics | Plasmodium falciparum | Cellular proteins | Genetic aspects | Parasite antigens | Research | Malaria vaccine | Animal models | Biomedical research | Transcription | Laboratories | Liver | Genes | Infections | DNA vaccines | Vaccines | Parasites | Immunity | Proteins | Immunology | Developmental stages | Lymphocytes | Tiling | Circumsporozoite protein | Deoxyribonucleic acid--DNA | Vector-borne diseases | Antigens | Immunoglobulins | Malaria | Gene expression | Mosquitoes | Infectious diseases | DNA microarrays | Deoxyribonucleic acid
Journal Article
Biotechnology Journal, ISSN 1860-6768, 10/2015, Volume 10, Issue 10, pp. 1651 - 1659
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 2018, Volume 12, pp. 25 - 40
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells. Approximately 30 different species of Phlebotomine sand flies can transmit... 
Vaccine | Leishmania treatment | Recombinant antigens | Leishmania | CONTROLLED-TRIAL | CHEMISTRY, MEDICINAL | leishmania | MAJOR PLUS BCG | CANINE VISCERAL LEISHMANIASIS | SUSCEPTIBLE BALB/C MICE | LIPOSOMAL AMPHOTERICIN-B | leishmania treatment | vaccine | PROTECTIVE IMMUNITY | RISK CHILD POPULATION | WORLD CUTANEOUS LEISHMANIASIS | CELLULAR IMMUNE-RESPONSE | PHARMACOLOGY & PHARMACY | recombinant antigens | SOLID-LIPID NANOPARTICLES | Leishmaniasis - immunology | Trypanocidal Agents - adverse effects | Antigens, Protozoan - immunology | Leishmaniasis - diagnosis | Leishmaniasis Vaccines - immunology | Leishmaniasis Vaccines - adverse effects | Humans | Leishmaniasis - drug therapy | Treatment Outcome | Leishmania - immunology | Animals | Antigens, Protozoan - therapeutic use | Leishmaniasis Vaccines - therapeutic use | Leishmania - drug effects | Trypanocidal Agents - therapeutic use | Antigens, Protozoan - adverse effects | Leishmaniasis - parasitology | Drug Therapy, Combination | Drug Resistance | Care and treatment | Parasite vaccines | Usage | Leishmaniasis | Research | Vector-borne diseases | Drugs | Therapy | Malaria | Medical treatment | Vaccination | Medical services | Bites | Infections | Vaccines | Drug development | Disease control | Immunity | Tropical diseases | Phagocytes | Side effects | Amphotericin B | Parasitic diseases | Signs and symptoms | Parasites | Drug resistance | Chemotherapy | Basins | leishmaniasis | different types of drugs
Journal Article
BioMed Research International, ISSN 2314-6133, 2017, Volume 2017, p. 1295038
Toxoplasma gondii can infect all warm-blooded animals including human beings. T. gondii dense granule protein 16 (TgGRA16) as a crucial virulence factor could... 
MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNIZATION | PARASITES | PROTECTIVE IMMUNITY | PROTEIN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | NEOSPORA | MICE | HOST-CELL NUCLEUS | STRATEGIES | Antigens, Protozoan - immunology | Toxoplasmosis, Animal - genetics | Humans | Vaccines, DNA - immunology | Protozoan Proteins - genetics | Toxoplasmosis, Animal - prevention & control | Vaccines, DNA - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Host-Parasite Interactions - genetics | Toxoplasmosis, Animal - parasitology | Antigens, Protozoan - therapeutic use | Antigens, Protozoan - genetics | Protozoan Vaccines - immunology | Drug Resistance - drug effects | Protozoan Vaccines - administration & dosage | Toxoplasma - pathogenicity | Drug Resistance - genetics | Animals | Toxoplasma - genetics | CD8-Positive T-Lymphocytes - drug effects | Drug Resistance - immunology | Vaccines, DNA - adverse effects | Mice | Protozoan Vaccines - adverse effects | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Prevention | DNA vaccines | Toxoplasmosis | Patient outcomes | Brain | IgG antibody | Homeotherms | CD8 antigen | Virulence | Immunoglobulin G | Vaccination | Chronic infection | Lymphocytes T | Infections | Vaccines | Parasites | Kinases | Interleukin 4 | Interleukin 2 | Lymphocytes | Deoxyribonucleic acid--DNA | Protozoa | Immunization | Immune response | Cytokines | Gene expression | CD4 antigen | Cysts | Plasmids | Interleukin 10 | Interferon
Journal Article
Parasitology International, ISSN 1383-5769, 02/2019, Volume 68, Issue 1, pp. 63 - 72
Clioquinol (5-chloro-7-iodoquinolin-8-ol or ICHQ) was recently showed to presents an effective antileishmanial action, causing changes in membrane... 
5-chloro-7-iodoquinolin-8-ol | Treatment | Visceral leishmaniasis | Toxicity | Delivery systems | DIAGNOSTIC-TEST | EFFICACY | DELIVERY-SYSTEMS | NEW-WORLD | CHITOSAN | TOPICAL TREATMENT | LIPOSOMAL AMPHOTERICIN-B | CUTANEOUS LEISHMANIASIS | NANOPARTICLES | PARASITOLOGY | Antigens, Protozoan - immunology | Immunoglobulin G - blood | Humans | Leishmaniasis, Visceral - immunology | Amphotericin B - toxicity | Clioquinol - administration & dosage | Clioquinol - immunology | Antibodies, Protozoan - blood | Th1 Cells | Micelles | Antigens, Protozoan - administration & dosage | Antigens, Protozoan - therapeutic use | Amphotericin B - administration & dosage | Leishmania mexicana - drug effects | Antiprotozoal Agents - toxicity | Poloxamer - administration & dosage | Cytokines - immunology | Poloxamer - chemistry | Clioquinol - therapeutic use | Parasite Load | Leishmaniasis, Visceral - drug therapy | Antiprotozoal Agents - immunology | Animals | Interferon-gamma - immunology | Antiprotozoal Agents - administration & dosage | Mice | Mice, Inbred BALB C | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Drug Delivery Systems - methods | Cytokines - biosynthesis | Interferon-gamma - biosynthesis | Leishmania mexicana - growth & development | Amphotericin B | Immunotherapy | Immunoglobulin G | Antiparasitic agents | Leishmaniasis | Permeability | Health aspects | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0137683 - e0137683
Journal Article
Journal Article